![Norman LaFrance](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Norman LaFrance
Corporate Officer/Principal bei
YMAS THER
Profil
Norman D.
LaFrance is currently Chief Development Officer at Y-mAbs Therapeutics, Inc. since 2024.
Former positions include Chief Medical Officer & Senior Vice President at Plus Therapeutics, Inc. from 2021 to 2024; Chief Medical Officer & Senior Vice President at Jubilant Pharma Ltd. from 2012 to 2022; Global Chief Medical Officer at Zevacor Pharma, Inc. from 2010 to 2012; Chief Medical Officer & SVP-Clinical Development at Molecular Insight Pharmaceuticals, Inc. from 2007 to 2010; VP-Global Pharmaceutical Research & Development at Bausch & Lomb, Inc. from 2005 to 2007; and Senior Vice President-Medical & Regulatory Affairs at Celltech Americas, Inc. from 2002 to 2005.
Education includes undergraduate and graduate degrees from Rensselaer Polytechnic Institute and a doctorate from the University of Arizona.
Aktive Positionen von Norman LaFrance
| Unternehmen | Position | Beginn |
|---|---|---|
| YMAS THER | Corporate Officer/Principal | 05.06.2024 |
Ehemalige bekannte Positionen von Norman LaFrance
| Unternehmen | Position | Ende |
|---|---|---|
| CERENOME, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.06.2024 |
Jubilant Pharma Ltd.
 Jubilant Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
Jubilant Pharma Holdings, Inc.
 Jubilant Pharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 |
Zevacor Pharma, Inc.
 Zevacor Pharma, Inc. Medical DistributorsDistribution Services Distributes and develops molecular imaging solutions | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | 05.11.2010 |
Ausbildung von Norman LaFrance
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Health Services |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Celltech Americas, Inc. | |
Zevacor Pharma, Inc.
Zevacor Pharma, Inc. Medical DistributorsDistribution Services Distributes and develops molecular imaging solutions | Distribution Services |
Jubilant Pharma Ltd.
Jubilant Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Jubilant Pharma Holdings, Inc.
Jubilant Pharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
